Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For Ws Ranibizumab (atc Code According To Who: S01la04) As An Injection Solution In A Pre-filled Syringe 2026-05-11
Germany Wound Care According To § 31 Sgb V 2026-05-11
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-05-11
Germany Non-excl. Drug-tracking Agreement According To § 130a Abs. 8 Sgb V By Means Of An Open-house Model To Ws Ranibizumab (atc Code According To Who: S01la04) As An Injection Solution In A Finished Injection 2026-05-11
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-05-11
Germany The Subject Of This Publication Is The Conclusion Of Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For Medicinal Products Containing The Active Ingredient Aflibercept (atc Code According To Who: S01la05; Excluding 114.3 Mg/ml) As An I 2026-05-11
Germany Conclusion Not Excluding Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For Ws Ranibizumab (atc Code According To Who: S01la04) As An Injection Solution In A Vial 2026-05-11
Germany The Subject Of This Publication Is The Conclusion Of Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For Medicinal Products Containing The Active Ingredient Aflibercept (atc Code According To Who: S01la05; Excluding 114.3 Mg/ml) As An I 2026-05-11
Poland Delivery Of Materials For Laboratory Tests 2026-05-11
Poland Modernization Of Rooms For Installation Of X-ray Machine 2026-05-11
Whats app